Arrhythmogenic Cardiotoxicity Associated With Contemporary Treatments of Lymphoproliferative Disorders

BACKGROUND: There are limited data on risk of arrhythmias among patients with lymphoproliferative disorders. We designed this study to determine the risk of atrial and ventricular arrhythmia during treatment of lymphoma in a real‐world setting. METHODS AND RESULTS: The study population comprised 206...

Descripción completa

Detalles Bibliográficos
Autores principales: Sherazi, Saadia, Schleede, Susan, McNitt, Scott, Casulo, Carla, Moore, Jeremiah E., Storozynsky, Eugene, Patel, Arpan, Vidula, Neelima, Aktas, Mehmet K., Zent, Clive S., Goldenberg, Ilan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111520/
https://www.ncbi.nlm.nih.gov/pubmed/36892046
http://dx.doi.org/10.1161/JAHA.122.025786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111520/
https://www.ncbi.nlm.nih.gov/pubmed/36892046
http://dx.doi.org/10.1161/JAHA.122.025786

Ejemplares similares